<VariationArchive RecordType="classified" VariationID="7256" VariationName="NM_005251.3(FOXC2):c.509del (p.Lys170fs)" VariationType="Deletion" Accession="VCV000007256" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-07-29" DateCreated="2019-01-05" MostRecentSubmission="2019-01-05">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="22295" VariationID="7256">
      <GeneList>
        <Gene Symbol="FOXC2" FullName="forkhead box C2" GeneID="2303" HGNC_ID="HGNC:3801" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16q24.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="86566829" stop="86569728" display_start="86566829" display_stop="86569728" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="86600856" stop="86602538" display_start="86600856" display_stop="86602538" Strand="+" />
          </Location>
          <OMIM>602402</OMIM>
          <Haploinsufficiency last_evaluated="2013-11-26" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FOXC2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2013-11-26" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FOXC2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_005251.3(FOXC2):c.509del (p.Lys170fs)</Name>
      <CanonicalSPDI>NC_000016.10:86567839:AAAAA:AAAA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16q24.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="86567840" stop="86567840" display_start="86567840" display_stop="86567840" variantLength="1" positionVCF="86567839" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="86601446" stop="86601446" display_start="86601446" display_stop="86601446" variantLength="1" positionVCF="86601445" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>K170fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1292" sequenceAccession="LRG_1292">
            <Expression>LRG_1292:g.6016del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1292t1" sequenceAccession="LRG_1292t1">
            <Expression>LRG_1292t1:c.509del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1292p1" sequenceAccession="LRG_1292p1" change="p.Lys170fs">
            <Expression>LRG_1292p1:p.Lys170fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005251.3" sequenceAccession="NM_005251" sequenceVersion="3" change="c.509del" MANESelect="true">
            <Expression>NM_005251.3:c.509del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005242.1" sequenceAccession="NP_005242" sequenceVersion="1" change="p.Lys170fs">
            <Expression>NP_005242.1:p.Lys170fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.86567844del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.86567844del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.86601450del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.86601450del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012025.2" sequenceAccession="NG_012025" sequenceVersion="2" change="g.6016del">
            <Expression>NG_012025.2:g.6016del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="FOXC2_000015" DB="LOVD 3" />
        <XRef Type="Allelic variant" ID="602402.0008" DB="OMIM" />
        <XRef Type="rs" ID="1567571276" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005251.3(FOXC2):c.509del (p.Lys170fs) AND Distichiasis-lymphedema syndrome" Accession="RCV000007678" Version="3">
        <ClassifiedConditionList TraitSetID="1971">
          <ClassifiedCondition DB="MedGen" ID="C0265345">Distichiasis-lymphedema syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2001-05-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2001-05-15" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-01-05" MostRecentSubmission="2019-01-05">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11371511</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1971" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2577" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Lymphedema with distichiasis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary lymphedema-distichiasis syndrome (subtype)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Distichiasis-lymphedema syndrome</ElementValue>
                <XRef ID="Lymphedema+distichiasis+syndrome/4357" DB="Genetic Alliance" />
                <XRef ID="8634009" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="333" />
                <XRef ID="333" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Lymphedema-distichiasis syndrome (referred to as LDS in this GeneReview) is characterized by lower-limb lymphedema, and distichiasis (aberrant eyelashes ranging from a full set of extra eyelashes to a single hair). Lymphedema typically appears in late childhood or puberty, is confined to the lower limbs with or without involvement of the external genitalia, and is often asymmetric; severity varies within families. Males develop edema at an earlier age and have more problems with cellulitis than females. Distichiasis, which may be present at birth, is observed in 94% of affected individuals. About 75% of affected individuals have ocular findings including corneal irritation, recurrent conjunctivitis, and photophobia; other common findings include varicose veins and ptosis.</Attribute>
                <XRef ID="NBK1457" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301630</ID>
                <ID Source="BookShelf">NBK1457</ID>
              </Citation>
              <XRef ID="33001" DB="Orphanet" />
              <XRef ID="C0265345" DB="MedGen" />
              <XRef ID="MONDO:0007922" DB="MONDO" />
              <XRef Type="MIM" ID="153400" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="27879" SubmissionDate="2019-01-02" DateLastUpdated="2019-01-05" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="602402.0008_LYMPHEDEMA-DISTICHIASIS SYNDROME" title="FOXC2, 1-BP DEL, 505A_LYMPHEDEMA-DISTICHIASIS SYNDROME" />
        <ClinVarAccession Accession="SCV000027879" DateUpdated="2019-01-05" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2001-05-15">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a family with lymphedema-distichiasis syndrome (LPHDST; 153400), Finegold et al. (2001) found a 1-bp deletion (505delA) in the FOXC2 gene, resulting in a frameshift with premature termination at amino acid 202. Age of onset of lymphedema ranged from 8 to 13 years among affected family members. Two individuals had ptosis, and 1 had tetralogy of Fallot.</Attribute>
              <Citation>
                <ID Source="PubMed">11371511</ID>
              </Citation>
              <XRef DB="OMIM" ID="153400" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FOXC2" />
          </GeneList>
          <Name>FOXC2, 1-BP DEL, 505A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 505A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="602402.0008" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">LYMPHEDEMA-DISTICHIASIS SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="27879" TraitType="Disease" MappingType="Name" MappingValue="LYMPHEDEMA-DISTICHIASIS SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C0265345" Name="Distichiasis-lymphedema syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

